This finding can be resonant with a review on why diabetes medication is so expensive and what can be done to control its cost, which found that the cost of antihyperglycemic medicines, especially insulin, has become a barrier to diabetes treatment (35–37). This evidence concerns the gene INS and diabetes mellitus.